509 related articles for article (PubMed ID: 18358567)
1. Care of the HIV-positive patient in the emergency department in the era of highly active antiretroviral therapy.
Venkat A; Piontkowsky DM; Cooney RR; Srivastava AK; Suares GA; Heidelberger CP
Ann Emerg Med; 2008 Sep; 52(3):274-85. PubMed ID: 18358567
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular disease and toxicities related to HIV infection and its therapies.
Zareba KM; Miller TL; Lipshultz SE
Expert Opin Drug Saf; 2005 Nov; 4(6):1017-25. PubMed ID: 16255661
[TBL] [Abstract][Full Text] [Related]
3. Increased health care utilization and increased antiretroviral use in HIV-infected individuals with mental health disorders.
Mijch A; Burgess P; Judd F; Grech P; Komiti A; Hoy J; Lloyd JH; Gibbie T; Street A
HIV Med; 2006 May; 7(4):205-12. PubMed ID: 16630032
[TBL] [Abstract][Full Text] [Related]
4. Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act.
Burgoyne RW; Tan DH
J Antimicrob Chemother; 2008 Mar; 61(3):469-73. PubMed ID: 18174196
[TBL] [Abstract][Full Text] [Related]
5. Dyslipidaemia and cardiovascular risk in HIV infection.
Kulasekaram R; Peters BS; Wierzbicki AS
Curr Med Res Opin; 2005 Nov; 21(11):1717-25. PubMed ID: 16307691
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal complications of HIV infection: changing priorities in the HAART era.
Wilcox CM; Saag MS
Gut; 2008 Jun; 57(6):861-70. PubMed ID: 18203808
[TBL] [Abstract][Full Text] [Related]
7. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S
Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181
[TBL] [Abstract][Full Text] [Related]
8. [Interactions of cardiac and antiretroviral medication].
Egger S; Drewe J
Herz; 2005 Sep; 30(6):493-503. PubMed ID: 16170680
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular disease prevention and treatment in patients with human immunodeficiency virus.
Magen E; Elbirt D; Sthoeger Z
Isr Med Assoc J; 2005 Apr; 7(4):252-6. PubMed ID: 15847207
[TBL] [Abstract][Full Text] [Related]
10. Rheumatic manifestations associated with HIV in the highly active antiretroviral therapy era.
Nguyen BY; Reveille JD
Curr Opin Rheumatol; 2009 Jul; 21(4):404-10. PubMed ID: 19444116
[TBL] [Abstract][Full Text] [Related]
11. First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006).
Carosi G; Quiros-Roldan E; Torti C; Antinori A; Bevilacqua M; Bonadonna RC; Bonfanti P; Castagna A; Cauda R; d'Arminio-Monforte A; Di Gregorio P; Di Perri G; Esposito R; Fatuzzo F; Gervasoni C; Giannattasio C; Guaraldi G; Lazzarin A; Lo Caputo S; Maggi P; Mazzotta F; Moroni M; Prestileo T; Ranieri R; Rizzardini G; Russo R; Galli M;
Infection; 2007 Jun; 35(3):134-42. PubMed ID: 17565453
[TBL] [Abstract][Full Text] [Related]
12. Hospitalizations of pregnant HIV-infected women in the United States in the era of highly active antiretroviral therapy (HAART).
Bansil P; Jamieson DJ; Posner SF; Kourtis AP
J Womens Health (Larchmt); 2007 Mar; 16(2):159-62. PubMed ID: 17388731
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus and atherosclerosis.
Farrugia PM; Lucariello R; Coppola JT
Cardiol Rev; 2009; 17(5):211-5. PubMed ID: 19690471
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients.
Kong HH; Myers SA
Dermatol Ther; 2005; 18(1):58-66. PubMed ID: 15842613
[TBL] [Abstract][Full Text] [Related]
15. Key data from the 11th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV.
Boehme RE; Cameron S
Antivir Ther; 2009; 14(8):1195-208. PubMed ID: 20032550
[TBL] [Abstract][Full Text] [Related]
16. Risk of cardiovascular disease in HIV-infected patients.
Das S
J Antimicrob Chemother; 2010 Mar; 65(3):386-9. PubMed ID: 20026610
[TBL] [Abstract][Full Text] [Related]
17. Review of transplantation in HIV patients during the HAART era.
Pelletier SJ; Norman SP; Christensen LL; Stock PG; Port FK; Merion RM
Clin Transpl; 2004; ():63-82. PubMed ID: 16704139
[TBL] [Abstract][Full Text] [Related]
18. Highly active antiretroviral therapy-associated metabolic syndrome: pathogenesis and cardiovascular risk.
Barbaro G
Am J Ther; 2006; 13(3):248-60. PubMed ID: 16772767
[TBL] [Abstract][Full Text] [Related]
19. How does HIV impact on non-AIDS events in the era of HAART?
Barber TJ; Hughes A; Dinsmore WW; Phillips A
Int J STD AIDS; 2009 Jan; 20(1):1-3. PubMed ID: 19103883
[TBL] [Abstract][Full Text] [Related]
20. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.
Madeddu G; Porqueddu EM; Cambosu F; Saba F; Fois AG; Pirina P; Mura MS
Infection; 2008 Jun; 36(3):231-6. PubMed ID: 18463787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
